Daniel P. Van Plew - Dec 8, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP & General Mgr, Industrial
Signature
/s/**Daniel P. Van Plew
Stock symbol
REGN
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 04:36 PM
Previous filing
Nov 17, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +4.34K +16.13% $0.00 31.3K Dec 8, 2021 Direct F1
holding REGN Common Stock 1.05K Dec 8, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +18.5K $0.00 18.5K Dec 8, 2021 Common Stock 18.5K $644.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.